Biosimilars [Design Issues]

posted by Kumarnaidu2 – India, 2021-10-22 09:53 (863 d 18:17 ago) – Posting: # 22653
Views: 1,436

Dear All,

For a medicinal product to be administer as intravenous infusion (for approx. 3 hrs) if we consider Ctrough as one of the primary pk parameter for demonstrating PK similarity, does different rate of infusion amongst enrolled subjects has any impact on Ctrough levels?

Thanks in advance,


Complete thread:

UA Flag
 Admin contact
22,919 posts in 4,807 threads, 1,643 registered users;
42 visitors (0 registered, 42 guests [including 6 identified bots]).
Forum time: 03:10 CET (Europe/Vienna)

The analysis of variance is not a mathematical theorem,
but rather a convenient method of arranging the arithmetic.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz